A largest player of Ibuprofen (pain killer) globally with a world market share of 35%
Positive: MCAP>2000 Cr., CMP close to 52 week low, RoE/RoCE>=10, PEG<1, No/Low debt, PE<15, Promoter holding ++
Negative: Poor sales growth/OPM%/Net Profit/EPS, FII/DII --
Seed/support at (bottom) entry, feed time to travel, harvest on resistance.
Positive: MCAP>2000 Cr., CMP close to 52 week low, RoE/RoCE>=10, PEG<1, No/Low debt, PE<15, Promoter holding ++
Negative: Poor sales growth/OPM%/Net Profit/EPS, FII/DII --
Seed/support at (bottom) entry, feed time to travel, harvest on resistance.